Sign in
4

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0001209191-22-009739

Options or other derivatives

  • Galletta Christopher acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Galletta Christopher

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-11 Grant or award : show line 1 in the form Stock Option (right to buy) +35,000 35,000 D
Loading xslF345X03/doc4.xml…